A Clinical Trial Evaluating TG4050 in Head and Neck Cancer

Clinical trial NCT04183166 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04183166
Sponsor: Transgene
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck

Start date: 2019-12-12
Primary completion: 2027-12-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.